Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), sold 25,000 shares at $2.60 ($65K) on 2011-01-11, disclosed to the SEC on 2011-01-13.
Scheduled sale ($65k) by CEO & Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |